Alterity Therapeutics Ltd
PRNAF- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001131343
In the last 90 days, Alterity Therapeutics Ltd insiders filed 1 open-market purchase and 0 sales; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Other share classesATHE
Holders of 5% or more of PRNAF
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Alterity Therapeutics Ltd, largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Alterity Therapeutics Ltd on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on Alterity Therapeutics Ltd, newest first.
No Schedule 13D or 13G filings on Alterity Therapeutics Ltd are on file.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Alterity Therapeutics Ltd shares.
No Form 144 notices for Alterity Therapeutics Ltd are on file.